Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Omega Diagnostics falls; Venture Life sales up

Mon, 31st Jan 2022 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Venture Life Group PLC, up 28% at 48.00 pence, 12-month range 27.00p-105.00p. The maker of self-care products expects to report a revenue rise of 8.3% to GBP32.6 million in 2021 from GBP30.1 million in 2020. Revenue increased by 35% to GBP18.7 million in the second half from GBP13.9 million in the first half. The Berkshire-based company develops products such as Dentyl mouthwash and Rosa Calma rosacea treatment range.

----------

Next Fifteen Communications Group PLC, up 12% at 1,215.00 pence, 12-month range 600.00p-1,350.00p. The media and marketing firm says revenue surges 34% in both the fourth quarter and the full year, which concludes on Monday. Results are ahead of market expectations and set up Next Fifteen for a "positive start to our new financial year", despite tough comparatives.

----------

AIM - LOSERS

----------

Omega Diagnostics Group PLC, down 26% at 7.86p, 12-month range 6.75p-117.98p. The Alva, Scotland-based medical diagnostics company confirms it is in talks with investors over a possible equity raise, following "recent online speculation". Omega says any cash raise will come at a discount but adds there is "no immediate need to raise additional capital". Shares hit the 12-month low on Monday.

----------

Tanfield Group PLC, down 10% at 2.02p, 12-month range 1.90p-3.96p. The investment firm says a delay by investee Snorkel in producing documents in US legal proceedings means a trial will be delayed. The US trial window is not expected to begin until August at the earliest. Back in October 2019, Tanfield said both Snorkel and and SKL Holdings LLC filed a summons and complaint against Tanfield. Tanfield has a 49% stake in Snorkel under its joint venture with Xtreme Manufacturing LLC. In November 2018, SKL exercised a call option for Tanfield's Snorkel interest at an option price of nothing. SKL also claimed it did not have to pay the priority amount and preferred return on the Snorkel stake. Tanfield disagreed, rejecting the call option notice's validity.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
30 May 2022 15:59

UK shareholder meetings calendar - next 7 days

Tuesday 31 May 
GYG PLCAGM
JTC PLCAGM
Lookers PLCAGM
McColl's Retail Group PLCAGM
Microlise Group PLCAGM
PageGroup PLCAGM
Petershill Partners PLCAGM
Sportech PLCAGM
Tekcapital PLCAGM
Wednesday 1 June  
Boku IncAGM
Parsley Box Group PLCAGM
One Media IP Group PLCAGM
United Oil & Gas PLCAGM
Flowtech Fluidpower PLCAGM
Dianomi PLCAGM
Honeycomb Investment Trust PLCGM re combination with Pollen Street Capital
East Imperial PLCAGM
Secure Income REIT PLCAGM
Public Policy Holding Co IncAGM
Thursday 2 June  
Clontarf Energy PLCGM re issue of new shares
HealthBeacon PLCAGM
Friday 3 June  
no events scheduled  
Monday 6 June  
Alphawave IP Group PLCAGM
Minoan Group PLCAGM
Omega Diagnostics Group PLCAGM
Sensyne Health PLCGM re strategic financing
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 12:31

IN BRIEF: Omega raises GBP2.0 million through placing and subscription

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Raises gross proceeds of GBP2.0 million via a placing of 50.0 million new shares and the issue of 90.0 million warrants at a price of 4.0 pence per share. Plans to use the proceeds to fund its CD4 business to divestment and provide additional working capital. Intends to dispose of the CD4 unit to focus solely on its Health & Nutrition business which contributes to the majority of its revenue. Plans to raise an additional GBP2.0 million by the issue of up to 49.9 million shares through an open offer. Expects its enlarged issued share capital to be 284.7 million shares, assuming full take-up of the open offer shares.

Read more
7 Apr 2022 14:30

IN BRIEF: Omega Diagnostics expects substantial annual revenue growth

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects to report revenue of GBP12.3 million for the year ended March 31, up 41% from GBP8.7 million the year before. Says Covid-19-related revenue grew 53% to GBP2.6 million from GBP1.7 million. Expects ongoing Covid-related income to be minimal. Notes that net cash balance was GBP1.5 million at year-end and that it has an overdraft facility of GBP2.0 million which remains in place and unutilised. Continues to actively explore alternative options to generate additional funds.

Read more
7 Apr 2022 11:06

Omega Diagnostics FY revenues surge, sees 'minimal' ongoing Covid income

(Sharecast News) - Medical diagnostics company Omega said on Thursday that full-year revenues were expected to have surged in 2021 but cautioned that ongoing Covid-related income was now anticipated to be minimal.

Read more
11 Mar 2022 16:10

Omega's professional-use Covid test rejected by UK regulator

(Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.

Read more
11 Mar 2022 11:15

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
7 Mar 2022 21:34

IN BRIEF: Omega completes conditional sale of manufacturing business

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics - Says it has completed the conditional sale agreement for Omega's diagnostic test kit manufacturing business and facility in Alva, Scotland. Agreement is with Accubio Ltd, a wholly-owned subsidiary of Zhejiang Orient Gene Biotech Co Ltd for a cash consideration of GBP1 million.

Read more
1 Mar 2022 20:32

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Feb 2022 14:21

Omega selling Scotland factory after government Covid test plans collapse

(Sharecast News) - Medical diagnostics specialist Omega has signed a conditional sale and purchase agreement with Accubio, a wholly-owned subsidiary of Orient Gene, for the sale of its diagnostic test kit manufacturing business and facility in Alva, Scotland.

Read more
11 Feb 2022 11:31

Omega shares down on discounted fundraise; sells Alva facility

(Alliance News) - Omega Diagnostics Group PLC on Friday announced that it had begun a GBP7.0 million fundraise as well as sold its manufacturing business in Alva, Scotland.

Read more
10 Feb 2022 14:37

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

Read more
3 Feb 2022 15:39

Omega gets CE-marking for Covid-19 test, working on UK approval

(Sharecast News) - Medical diagnostics specialist Omega has successfully CE-marked its 'Visitect' Covid-19 antigen test for self-test use, it announced on Thursday.

Read more
3 Feb 2022 14:35

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

Read more
3 Feb 2022 11:00

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.